This scaffolding capacity of KIF12 may be apart from the kinesin motor activity, because the motor-less KIF12-PRD overexpression can still ameliorate the steatosis either in KIF12 KD cells, in lipid-treated cells, or in human patient hiHep cells (Figs. 3 and EV3). Here, KIF12 is linked to steatosis.